GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (XSWX:CURN) » Definitions » Total Stockholders Equity

Curatis Holding AG (XSWX:CURN) Total Stockholders Equity : CHF41.59 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Curatis Holding AG Total Stockholders Equity?

Curatis Holding AG's Total Stockholders Equity for the quarter that ended in Jun. 2024 was CHF41.59 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Curatis Holding AG's Book Value per Share for the quarter that ended in Jun. 2024 was CHF9.49. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Curatis Holding AG's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.00.

Curatis Holding AG Total Stockholders Equity Historical Data

The historical data trend for Curatis Holding AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Total Stockholders Equity Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Total Stockholders Equity
-0.40 6.75 -0.31

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Stockholders Equity Get a 7-Day Free Trial 37.94 6.75 6.22 -0.31 41.59

Curatis Holding AG  (XSWX:CURN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Curatis Holding AG's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(41.593-0)/4.38401
=9.49

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Curatis Holding AG's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 41.593
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curatis Holding AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Curatis Holding AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (XSWX:CURN) » Definitions » Total Stockholders Equity
Comparable Companies
LSE:INDV LSE:HIK LSE:EAH LSE:ANCR LSE:PXS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX SZSE:300122 BGNE ALNY OCSE:GMAB BMRN
Traded in Other Exchanges
CURNz:UK 0QNS:UK
Address
Weierweg 7, Liestal, CHE, CH-4410
Website
https://www.curatis.com
Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.